Latest Corporate News News
Fifth Third Completes Merger with Comerica, Becoming 9th Largest U.S. Bank
Fifth Third Bancorp closed its merger with Comerica, creating a bank with $294 billion in assets and operations in 17 of the 20 fastest-growing U.S. markets. The deal enhances retail banking, digital capabilities, and middle market expertise, with plans for 1,750 branches by 2030.
CEO Tim Spence highlighted opportunities in scaling commercial payments and innovation banking.
Netflix Announces $82.7 Billion Acquisition of Warner Bros. Discovery
Netflix revealed a massive $82.7 billion deal to acquire Warner Bros. Discovery, with terms updated in January 2026. This marks one of the major early-year M&A transactions amid rising corporate optimism.
The acquisition reflects surging M&A activity projected for 2026.
Global Payments Completes $24.25 Billion Bid for Worldpay
Global Payments finalized its $24.25 billion acquisition of Worldpay, boosting its payments processing capabilities. The deal is part of a hot M&A market kickoff in 2026.
Executives cite proactive growth strategies driving such transactions.
Boston Scientific Plans $14.5 Billion Purchase of Penumbra
Boston Scientific announced a $14.5 billion deal to acquire Penumbra Inc., expanding its medical device portfolio. The transaction kicked off major January M&A activity in healthcare.
It positions Boston Scientific for growth in neurovascular technologies.
Eli Lilly Acquires Ventyx Biosciences for $1.2 Billion
Eli Lilly launched an all-cash $1.2 billion acquisition of Ventyx Biosciences, focusing on inflammatory and autoimmune disease treatments. The deal, expected to close in H1 2026, bolsters Lilly's pipeline.
It highlights ongoing pharma M&A surge exceeding $50 billion in January.
AstraZeneca Acquires AbelZeta Pharma Rights for $630 Million
AstraZeneca secured rights to AbelZeta’s GPC3-armored CAR-T therapy for solid tumors in a $630 million deal. This reinforces AstraZeneca's cell therapy strategy.
The transaction underscores interest in next-generation CAR-T technologies.
SoftBank Group to Acquire DigitalBridge Group for $8-9 Billion
SoftBank announced plans to acquire DigitalBridge Group in an $8-9 billion infrastructure-tech deal in early January 2026. The mixed-use acquisition targets infrastructure and technology sectors.
It exemplifies billion-dollar deals shaping H1 2026.
Alphabet and Amazon Set to Report Earnings Amid AI Scrutiny
Alphabet and Amazon are scheduled to release earnings this week, with focus on cloud growth and AI infrastructure spending. Investors will assess Magnificent 7 performance post recent tech divergences.
Pharma giants like Eli Lilly and Novo Nordisk also report.
M&A Activity Expected to Surge in 2026 with AI Driving Deals
Corporate leaders anticipate a hot year for mergers and acquisitions, with 62% of U.S. CEOs planning active pursuit. AI adoption in dealmaking provides competitive edges, per Deloitte, EY, and Bain surveys.
Global M&A rose 40% to $4.9 trillion in 2025, setting records.
Charles River Laboratories Acquires K.F. Ltd. in Cambodia
Charles River Laboratories bought K.F. Ltd., a Cambodia-based provider, as part of January M&A deals. The acquisition expands its preclinical services footprint.
It aligns with broader healthcare sector consolidation trends.
AbbVie Partners with RemeGen for $5.6 Billion PD-1/VEGF Drug Rights
AbbVie secured global ex-China rights to RemeGen's RC148 immunotherapy in a $5.6 billion deal announced at JPM 2026. This contributes to over $50 billion in January pharma BD&M.
It targets oncology advancements.
SanDisk Shares Soar 21.6% on AI-Driven Revenue Surge
SanDisk stock rose 21.6% after Q4 revenue jumped 61% YoY from AI data center NAND flash demand. This contrasted with Microsoft's 7.7% drop on Azure growth concerns.
Tech earnings divergence highlights AI sector dynamics.